China-US Divide Deepens On Covid Vaccines, Azar Taiwan Visit
CanSino to Start Vaccine Trial in Mexico
Executive Summary
China has shown willingness to go tit-for-tat in its bilateral disputes with the US and the latest comments from US officials show an underlying distrust over clinical data and vaccines safety in China, raising fresh concerns just when collaboration is needed to accelerate availability of the first vaccines in the global pandemic.
You may also be interested in...
Coronavirus Notebook: UK Ups Vaccine Efforts & Calls For More Candidate Therapies
The UK has been stepping up its COVID-19 activity in recent days, ordering more vaccines, encouraging more volunteers to join clinical trials, and expanding its RECOVERY platform for potential new coronavirus therapies. But the government's sudden decision to replace Public Health England with a new institute has raised some concerns within the biopharma industry.
Russia Approves First COVID-19 Vaccine
The Russian ministry of health has raised eyebrows by approving a vaccine against SARS-CoV-2 just weeks after its first clinical trials in 76 volunteers. Phase III confirmatory studies await for the adenovirus-based product but a mass vaccination plan is slated to begin in October.
World First Or Beating The US? China Ups COVID-19 Vaccines Game
Touting its coronavirus vaccines as a "global public good", China is quietly preparing for the first general approvals and launches, possibly within weeks, developers say. But who will be first in line to receive them? And at what cost? Distribution and pricing are just some of the unanswered questions.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: